DEGRADED AGONIST ANTIBODY
First Claim
Patent Images
1. A modified antibody comprising two or more H chain V regions and two or more L chain V regions of the same or different monoclonal antibody and showing an agonist action by crosslinking a cell surface molecule(s) or intracellular molecule(s).
0 Assignments
0 Petitions
Accused Products
Abstract
The invention relates to a modified antibody which contains two or more H chain V regions and two or more L chain V regions of monoclonal antibody and can transduce a signal into cells by crosslinking a cell surface molecule(s) to thereby serve as an agonist. The modified antibody can be used as a signal transduction agonist and, therefore, useful as a preventive and/or remedy for various diseases such as cancer, inflammation, hormone disorders and blood diseases.
136 Citations
44 Claims
- 1. A modified antibody comprising two or more H chain V regions and two or more L chain V regions of the same or different monoclonal antibody and showing an agonist action by crosslinking a cell surface molecule(s) or intracellular molecule(s).
-
2. The modified antibody comprising two or more H chain V regions and two or more L chain V regions of monoclonal antibody and showing an agonist action by crosslinking a cell surface molecule(s).
- 26. A compound comprising two or more H chain V regions and two or more L chain V regions of monoclonal antibody and showing an equivalent or better agonist action (ED50) compared with a natural ligand that binds to a cell surface molecule(s) or intracellular molecule(s).
- 35. A method of inducing an agonist action to cells which comprises administering the first ligand and the second ligand that bind to a cell surface molecule(s) or intracellular molecule(s) and administering a substance that binds to the first and the second ligands and crosslinks the first and the second ligands.
-
42. A method of screening a modified antibody comprising two or more H chain V regions and two or more L chain V regions of antibody and showing an agonist action by crosslinking a cell surface molecule(s) or intracellular molecule(s) which comprises the steps
(1) to produce a modified antibody comprising two or more H chain V regions and two or more L chain V regions of antibody and binding specifically to a cell surface molecule(s) or intracellular molecule(s), (2) to subject cells expressing said cell surface molecule(s) or intracellular molecule(s) to react with the modified antibody and (3) to measure the agonist action in the cells caused by crosslinking said cell surface molecule(s) or intracellular molecule(s).
-
43. A method of measuring an agonist action of a modified antibody comprising two or more H chain V regions and two or more L chain V regions of antibody and showing an agonist action by crosslinking a cell surface molecule(s) or intracellular molecule(s) which comprises the steps
(1) to produce a modified antibody comprising two or more H chain V regions and two or more L chain V regions of antibody and binding specifically to a cell surface molecule(s) or intracellular molecule(s), (2) to subject cells expressing said cell surface molecule(s) or intracellular molecule(s) to react with the modified antibody and (3) to measure the agonist action in the cells caused by crosslinking said cell surface molecule(s) or intracellular molecule(s).
Specification